Meta Description: Lunair Medical announces active recruitment for its clinical trial on neurostimulator implants targeting Sleep Disordered Breathing and Sleep Apnea.
Lunair Medical is advancing sleep medicine with its latest development—a neurostimulator implant specifically designed to address Sleep Disordered Breathing (SDB) and Sleep Apnea. This innovation represents a critical step forward in non-invasive approaches for managing these serious conditions. As of November 24, 2025, the trial is actively recruiting participants.
In this article
- What is this clinical trial about?
- Which conditions does it address?
- How does the neurostimulator implant work?
- Frequently Asked Questions
- What does this mean for healthcare?
- Professional Disclaimer
- Learn More
What is this clinical trial about?
According to ClinicalTrials.gov, Lunair Medical is conducting a study that explores the safety and efficacy of a neurostimulator implant designed for patients with Sleep Disordered Breathing (SDB), including those diagnosed with Sleep Apnea. Currently, the trial is in its recruitment stage, aiming to enroll qualified participants for further evaluation.
Participants will receive the neurostimulator implant. This device delivers targeted electrical stimulation to regulate breathing patterns during sleep, providing an innovative approach to managing conditions that are traditionally treated with other mechanisms, such as continuous positive airway pressure (CPAP) devices.
Which conditions does it address?
The neurostimulator implant aims to effectively treat two prevalent sleep disorders:
- Sleep Disordered Breathing (SDB): SDB includes a spectrum of conditions characterized by abnormal breathing patterns during sleep, impacting oxygen levels and sleep quality.
- Sleep Apnea: A subcategory of SDB, Sleep Apnea involves repeated interruptions in breathing, often leading to cardiovascular, metabolic, and cognitive health issues.
Both conditions significantly affect patients’ quality of life and require urgent attention.
How does the neurostimulator implant work?
The neurostimulator implant operates by stimulating targeted nerves to regulate muscle activity linked to breathing during sleep. Unlike CPAP machines, which use constant airflow to keep the airway open, this neurostimulation device works at the source by influencing the neuromuscular pathways associated with respiratory function. This mechanism could offer increased comfort and compliance among patients who experience challenges with conventional treatments.
Detailed performance data regarding the implant’s effectiveness and patient outcomes will be evaluated during the trial phase.
Frequently Asked Questions
- Who is eligible for the study?
Eligibility criteria include individuals diagnosed with SDB or Sleep Apnea and meeting clinical parameters outlined by Lunair Medical. - How can interested participants enroll?
Interested individuals can visit the official ClinicalTrials.gov listing at the provided link to review trial details and enrollment procedures. - Is the device cleared for commercial use?
No, the neurostimulator implant is currently under investigation and is not yet cleared for widespread commercial use.
What does this mean for healthcare?
If successful, this clinical trial could revolutionize the management of SDB and Sleep Apnea, offering an alternative to traditional treatments. By leveraging neurostimulation, Lunair Medical seeks to improve patient compliance and overall therapeutic outcomes. This aligns with current trends advocating more personalized and less intrusive medical device solutions.
Healthcare providers and regulatory teams may want to monitor this trial closely as it progresses, given its potential impact on treatment protocol development.
Professional Disclaimer
This blog post is intended for informational purposes only and does not constitute legal or regulatory advice. Interested parties should consult with relevant experts for personalized guidance.
Learn More
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07243405?term=medical+device